Gonorrhea prevention and clinical care in the private sector: lessons learned and priorities for quality improvement

Sexually Transmitted Diseases
Guoyu Tao, Kathleen L Irwin

Abstract

We reviewed literature on gonorrhea prevention and clinical care in the private sector, the setting where most gonorrhea cases in the United States are now diagnosed. Although most private-sector health settings had a low prevalence of gonorrhea (0.1-2.5%), some private emergency departments and specialty clinics that serve a large number of high-risk or infected patients had prevalences ranged from 1.7% to 11.0%. Studies of diverse settings and populations suggest that, in general, diagnostic testing of symptomatic patients (69-83%), appropriate treatment (61-100%), and case reporting (64-94%) are delivered more commonly than risk assessment for asymptomatic patients (15-28%), routine screening of pregnant women (31-77%), risk-reduction counseling (35-78%), and sex partner management (0-82%). To sustain the recent declines in gonorrhea incidence in the United States, private-sector providers and health systems must continue to offer gonorrhea prevention and clinical services and consider implementing interventions to improve delivery of risk assessment, risk-reduction counseling, and partner management services.

References

May 1, 1995·Sexually Transmitted Diseases·D R Smucker, J C Thomas
Mar 1, 1994·The Journal of Pediatrics·H L KaramanoukianP L Glick
Mar 1, 1994·MCN. the American Journal of Maternal Child Nursing·B E Bishop
Feb 1, 1996·American Journal of Epidemiology·J C ThomasJ A Earp
Jan 1, 1996·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·M K OhJ B Hodgens
Oct 7, 1997·American Journal of Public Health·K J MertzA Hadgu
Oct 23, 1997·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·D M YealyG D Hobbs
Mar 13, 1998·JAMA : the Journal of the American Medical Association·R A GunnJ N Wasserheit
Mar 28, 1998·The American Journal of Emergency Medicine·T D KirschM Barron
Apr 18, 1998·JAMA : the Journal of the American Medical Association·L O Gostin, D W Webber
Jun 25, 1998·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·J R CatesW Cates
Jan 23, 1999·Infectious Diseases in Obstetrics and Gynecology·E CardonickN S Silverman
Jan 26, 1999·Pediatrics·B O BoekelooL J D'Angelo
Dec 8, 1997·Journal of Public Health Management and Practice : JPHMP·W E LaffertyH H Handsfield
Jul 20, 1999·JAMA : the Journal of the American Medical Association·S RoushD Fleming
Oct 26, 1999·Sexually Transmitted Diseases·C EubanksW J Kassler
Dec 2, 2000·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·J J KellyF Njuki
Dec 15, 2000·Journal of Acquired Immune Deficiency Syndromes : JAIDS·J E MaherM L Kamb
Feb 22, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S D MehtaJ M Zenilman
Feb 28, 2001·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·A R LifsonC R Hayman
Mar 10, 2001·American Journal of Public Health·C S ToddB P Stoner
May 19, 2001·Journal of Pediatric and Adolescent Gynecology·B SchroederS P Hertweck
May 30, 2001·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·W E LaffertyA Lind
Jul 14, 2001·Archives of Pediatrics & Adolescent Medicine·K SmithR J DiClemente
Jul 12, 2001·The American Journal of Emergency Medicine·D R WiestJ M Bartfield
Jul 21, 2001·Health Affairs·L RandelE J Emanuel
Sep 25, 2001·Archives of Pediatrics & Adolescent Medicine·P O OzuahS P Shelov
Sep 4, 2001·AIDS Patient Care and STDs·J BluespruceR S Thompson
Sep 25, 2001·American Journal of Obstetrics and Gynecology·R M RamusG D Wendel
Feb 20, 2002·JAMA : the Journal of the American Medical Association·Charles F TurnerJonathan M Zenilman
May 25, 2002·Health Affairs·Nadereh PouratWilliam Kassler

❮ Previous
Next ❯

Citations

Oct 30, 2012·The Journal of Emergency Medicine·Wiley D JenkinsPatricia Kissinger
Jan 4, 2020·MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports·Roxanne Y BarrowKimberly A Workowski

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.